What Is Alto Neuroscience, Inc. (ANRO) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Alto Neuroscience, Inc.'s intrinsic value is estimated at a composite fair value of $19.59. Trading at $27.76, the stock is approaching fair value or slight overvaluation (implied return of -29.4%), as 5 of 7 models suggest limited further upside. Notably, First Chicago sees the most upside at +79.0% (fair value: $49.69), while ML-RIV is the most conservative at -92.6% ($2.06). The spread between these extremes — +171.6% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About ANRO?
7 of 13 models are currently active for ANRO. Of these, 2 models suggest upside while 5 models suggest overvaluation. The Bayesian DCF estimates ANRO's intrinsic value at $8.79, implying -68.4% downside from the current price. See which stocks rank higher →
How Does ANRO Rank in Biotechnology?
Among 76 Biotechnology stocks, ANRO ranks #40 by Quality of Company score. CirclFi's QOC score of 4.8/10 evaluates 32 fundamental signals. A score of 4.8 reflects mixed fundamentals.
See all Most Undervalued Biotechnology Stocks →
The Biotechnology sector introduces analytical considerations specific to life sciences company businesses. For Alto Neuroscience, Inc., metrics like market exclusivity window provide important context that general-purpose valuation models may underweight.
Is ANRO a Value Trap?
CirclFi's Value Trap algorithm assigns ANRO a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for Alto Neuroscience, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Alto Neuroscience, Inc. scores 4.8 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +171.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ANRO valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ANRO's 7 active models, average confidence is 24%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad